That is very important, because the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (biotech stocks). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're developed to do. This was an advancement nearly no one discovered. But it's going to have profound implications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 1 biotech company). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back perhaps considerably prior to going higher - jeff brown biotech stock pick for 2020. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. bleeding edge. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many terrific private business on the brink of striking the general public markets And I have actually been working on a brand-new method for you to invest even before these companies go public.
This opportunity has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to schedule your spot free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers understand that tech isn't our typical beat (jeff brown predictions for 2021). And when it pertains to tech investing, we leave it to the specialists. Luckily, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (jeff brown stock predictions). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and much more. These trends are experiencing rapid development and producing incredible opportunities for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. future report review. But in spite of what numerous readers might believe, this is a trend that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2021 predictions). Losing two months of production and sales really impacts the number of 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is amazing. More importantly, the delays brought on by the pandemic produced a lots of suppressed need. And that demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - legacy report prediction. Which's not my only 5G forecast When I've discussed 5G in the past, I've described its three various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be used (future report). That's when we begin to see applications running on 5G networks. Think about things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage 3 by this summertime. This starts something of a virtuous cycle: Many people do not actually care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next important innovation I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar idea but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And throughout that time, there were really only three companies operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is successfully a greenfield chance.
There's space for many business to exist in this area. democratic republic. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary because the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced using this technology. This was among those breakthroughs that nearly no one discovered. However it's going to have extensive ramifications for curing disease. And, of course, there will be lots of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly before going greater. I have actually been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin - jeff brown predictions for 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. white house. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we could not individually verify this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to choose winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's constantly on the hunt for new chances, and he shares much of his finest choices in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted a few of the most significant financial occasions of the past twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, but Jeff Brown's accurate predictions have earned him legions of devoted fans. That states a lot about his capability. The Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research study provides several research services with a wide array of expertises - jeff brown.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown 2021 stock picks. On its website, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the best financial investment research has not been offered to individual investors. It has been usually booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown prediction for 2021. The mission of Brownstone Research study is to make that type of proprietary research study offered to any financiers seeking to get an edge in the markets. The objective is easy to provide special and rewarding investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown 1 biotech company. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown believes S.A.V. genetic sequencer stock jeff brown. could be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge innovations: expert system and electrical vehicles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automotive market's Holy Grail. As you understand, electric lorries and self-driving automobile stocks have been huge this year, however the Wall Street device has actually been huge on buzz without much tangible result. Regardless of a drastic boost in competitors over the previous couple of years, Brown still believes Musk has the finest opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would allow you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the revenues. It sounds crazy, however it could be closed than you think.